Debate continues over implantable cardioverter defibrillators in hypertrophic cardiomyopathyBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7613.229-a (Published 02 August 2007) Cite this as: BMJ 2007;335:229
Hypertrophic cardiomyopathy is a highly variable disease that is often benign but can be lethal. Implantable cardioverter defibrillators reduce the risk of lethal arrhythmias, but not everyone needs one, and selecting the patients most likely to benefit remains a challenge. In one …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial